Clinical Trial Update: A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB) [Phase 2]

View source ↗

Summary

Phase 2 study of LY3154207 in Lewy body dementia associated with Parkinson's disease or dementia with Lewy bodies has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lewy Body Dementia

Drugs mentioned

• LY3154207

Snippet

Sponsor: Eli Lilly and Company | Conditions: Lewy Body Dementia | Phase 2 | Status: COMPLETED | Results posted: 2021-07-23